According to filings with the U.S. Securities and Exchange Commission, Zuno Medical, Inc. is raising up to $19,913,424.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About Zuno Medical, Inc.
Zuno Medical is an innovative technology organization headquartered in Campbell, CA whose mission is to improve patient outcomes by providing groundbreaking solutions to advance healthcare. Specializing in breakthrough devices, Zuno Medical has developed the Zuno Smart Container, the worlds first verifiable vacuum-sealed sterilization container, eliminating compromised surgical instruments from entering an operating room. .

To learn more about Zuno Medical, Inc., visit https://zunomedical.com/
Zuno Medical, Inc. Linkedin Page: https://www.linkedin.com/company/zuno-medical-inc/

Contact:
Allam McNichol, Chief Executive Officer
650-382-2994
https://www.linkedin.com/in/allanmcnichol/

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.